Abstract
Summary
The daily intravenous administration of 3.0 mg of CF to two patients with pernicious anemia in relapse was followed by a satisfactory clinical remission, poor reticulocyte response, suboptimal hemoglobin and red blood cell levels in one case and a normal blood count in the other. The subsequent intramuscular injection of the same dose to the first patient resulted in a good hematologic remission.
Get full access to this article
View all access options for this article.